Welcome to the investor relations center of Accelerate Diagnostics, Inc. Here you will find a wealth of information regarding the company’s performance to date, recent filings, and our strategy for the continued growth of our business.
Accelerate Diagnostics, Inc. is an in-vitro diagnostics company dedicated to providing solutions for the global challenge of antibiotic resistance and hospital acquired infections. Our focus is developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens.
If you have questions or comments please contact our Investor Relations team by clicking here. We will be happy to help!
Jan 10, 2018
Accelerate Diagnostics achieves CE-IVD milestone for severe bacterial pneumonia assay, doubles revenue for 2017 in Q4
Jan 4, 2018
Accelerate Diagnostics to Present at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco
Nov 27, 2017
Accelerate Diagnostics Joins Sepsis Alliance in Global #GivingTuesday Movement to Raise Awareness of Sepsis as Medical Emergency